Risk factors for herpes zoster in Korean patients with rheumatoid arthritis treated with JAK inhibitor: a nested case-control study.

Yeo-Jin Song Soo Kyung ChoHyoungyoung KimHye Won KimEunwoo NamChan-Bum ChoiTae Hwan KimJae-Bum JunSang-Cheol BaeDae Hyun YooYoon-Kyoung Sung

Published in: RMD open (2022)

The number of previous targeted therapies, but not JAKi use, was identified as a risk factor for HZ development in Korean patients with RA in a real-world setting. High disease activity was an additional risk factor for JAKi users.

Keyphrases

disease activity
rheumatoid arthritis

systemic lupus erythematosus
rheumatoid arthritis patients

ankylosing spondylitis
juvenile idiopathic arthritis

interstitial lung disease
case control